Drug targeting an enzyme responsible for insulin resistance found to cure type 2 diabetes, preliminary study reveals.
-Researchers from a recent study, conducted by the University of California, studied the effect of a drug on insulin resistant mice.
-As per the study, the daily dose of the drug was found to cure type II diabetes in the insulin resistant mice.
-The novel drug was found to target the action of LMPTP (low molecular weight protein tyrosine phosphate) which is found to bring about insulin resistance.
-The study proved that LMPTP is a key promotor of insulin resistance and inhibitors to the same would help to treat type 2 diabetes effectively.
-No significant side effects were observed. The experts would now check the efficacy of the drug on the humans through clinical trials.
-Findings were published in The Nature.
Source: The Nature